Literature DB >> 8606378

Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention.

F P Perera1.   

Abstract

Recent molecular epidemiologic research provides compelling new evidence that environmental factors are major contributors to human cancer and that their risks are strongly influenced by genetic and acquired susceptibility. In particular, molecular epidemiology has demonstrated substantial variability in biologic response to carcinogens and suggests that certain groups-such as the very young, those with predisposing genetic traits or nutritional deficits, and even certain ethnic groups-are likely to have greater risk from selected exposures than other members of the population. This work implies that major gains in prevention of cancer, which will claim more than 554 000 American lives this year, will necessitate health and regulatory policies that protect these more susceptible groups and individuals from risks of man-made and naturally occurring environmental carcinogens. The specific implication from this research is that, to be effective in prevention, risk assessments developed in support of these policies by regulatory bodies, such as the Environmental Protection Agency, should reflect the available scientific data on individual variability in both exposure and susceptibility.

Entities:  

Mesh:

Year:  1996        PMID: 8606378     DOI: 10.1093/jnci/88.8.496

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  36 in total

1.  High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum.

Authors:  N Bodak; S Queille; M F Avril; B Bouadjar; C Drougard; A Sarasin; L Daya-Grosjean
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 2.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

Review 3.  Insurance underwriting in the genetic era.

Authors:  R J Pokorski
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

4.  Template-directed dye-terminator incorporation (TDI) assay: a homogeneous DNA diagnostic method based on fluorescence resonance energy transfer.

Authors:  X Chen; P Y Kwok
Journal:  Nucleic Acids Res       Date:  1997-01-15       Impact factor: 16.971

5.  Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells.

Authors:  S Hartmann; U Kriegebaum; N Küchler; R C Brands; C Linz; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2013-02-21       Impact factor: 3.573

Review 6.  Lung cancer. 1: prevention of lung cancer.

Authors:  G E Goodman
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

7.  Polymorphisms of CYP1A1, GSTM1 and GSTT1 Loci as the Genetic Predispositions of Oral Cancers and Other Oral Pathologies: Tobacco and Alcohol as Risk Modifiers.

Authors:  Sumana Chatterjee; Soujatya Dhar; Bani Sengupta; Ashish Ghosh; Manas De; Sumit Roy; Sila Chakrabarti
Journal:  Indian J Clin Biochem       Date:  2010-08-25

8.  The search for cancer risk factors: when can we stop looking?

Authors:  C B Begg
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

Review 9.  Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy.

Authors:  Navin Pinto; Susan M Ludeman; M Eileen Dolan
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

10.  Identification of CYP2C9*2 allele in HepG2 cell line.

Authors:  Jiezhong Chen; Kenneth Raymond
Journal:  Int J Gastrointest Cancer       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.